9 Meters Biopharma, Inc.
NMTRQ
$0.00
$0.000.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -13.87M | -11.93M | -9.35M | -11.13M | -11.35M |
| Total Depreciation and Amortization | 1.30K | 2.50K | 1.60K | 2.80K | 1.60K |
| Total Amortization of Deferred Charges | 578.90K | 1.33M | 500.40K | -- | -- |
| Total Other Non-Cash Items | 1.23M | 404.60K | 653.00K | 2.27M | 690.00K |
| Change in Net Operating Assets | 2.31M | 452.90K | -1.77M | 1.07M | 911.80K |
| Cash from Operations | -9.75M | -9.74M | -9.97M | -7.79M | -9.75M |
| Capital Expenditure | -- | 0.00 | 0.00 | 0.00 | -2.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | 0.00 | 0.00 | -2.80K |
| Total Debt Issued | -- | 0.00 | 21.00M | -- | -- |
| Total Debt Repaid | -16.75M | -- | -- | -- | -- |
| Issuance of Common Stock | 5.00M | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -537.70K | 0.00 | -1.09M | -- | -- |
| Cash from Financing | -12.29M | 0.00 | 19.91M | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.04M | -9.74M | 9.94M | -7.79M | -9.75M |
